Literature DB >> 23164510

The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus.

John A Evans, Dayna S Early, Norio Fukami, Tamir Ben-Menachem, Vinay Chandrasekhara, Krishnavel V Chathadi, G Anton Decker, Robert D Fanelli, Deborah A Fisher, Kimberly Q Foley, Joo Ha Hwang, Rajeev Jain, Terry L Jue, Khalid M Khan, Jenifer Lightdale, Phyllis M Malpas, John T Maple, Shabana F Pasha, John R Saltzman, Ravi N Sharaf, Amandeep Shergill, Jason A Dominitz, Brooks D Cash.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23164510     DOI： 10.1016/j.gie.2012.08.004

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  101 in total

Review 1.  Endoscopic options for treatment of dysplasia in Barrett's esophagus.

Authors:  R Brooks Vance; Kerry B Dunbar
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

Review 2.  Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.

Authors:  Kavel Visrodia; Siddharth Singh; Rajesh Krishnamoorthi; David A Ahlquist; Kenneth K Wang; Prasad G Iyer; David A Katzka
Journal:  Gastroenterology       Date:  2015-11-24       Impact factor: 22.682

Review 3.  Endoluminal therapies for Barrett's esophagus.

Authors:  Carmen L Mueller; Lorenzo E Ferri
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

4.  The essence of management of Barrett's esophagus.

Authors:  Kenneth K Wang
Journal:  Gastrointest Endosc       Date:  2013-11       Impact factor: 9.427

Review 5.  Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.

Authors:  Magnus Halland; David Katzka; Prasad G Iyer
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.

Authors:  Theresa Nguyen; Aaron P Thrift; Xiaoying Yu; Zhigang Duan; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2017-02-28       Impact factor: 10.864

7.  Predictors of Progression in Barrett's Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry.

Authors:  Rajesh Krishnamoorthi; Jason T Lewis; Murli Krishna; Nicholas J Crews; Michele L Johnson; Ross A Dierkhising; Brenda F Ginos; Kenneth K Wang; Herbert C Wolfsen; David E Fleischer; Francisco C Ramirez; Navtej S Buttar; David A Katzka; Prasad G Iyer
Journal:  Am J Gastroenterol       Date:  2017-04-04       Impact factor: 10.864

Review 8.  Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Authors:  Sachin Wani; V Raman Muthusamy; Nicholas J Shaheen; Rena Yadlapati; Robert Wilson; Julian A Abrams; Jacques Bergman; Amitabh Chak; Kenneth Chang; Ananya Das; John Dumot; Steven A Edmundowicz; Glenn Eisen; Gary W Falk; M Brian Fennerty; Lauren Gerson; Gregory G Ginsberg; David Grande; Matt Hall; Ben Harnke; John Inadomi; Janusz Jankowski; Charles J Lightdale; Jitin Makker; Robert D Odze; Oliver Pech; Richard E Sampliner; Stuart Spechler; George Triadafilopoulos; Michael B Wallace; Kenneth Wang; Irving Waxman; Srinadh Komanduri
Journal:  Am J Gastroenterol       Date:  2017-06-01       Impact factor: 10.864

9.  In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).

Authors:  Marcia Irene Canto; Sharmila Anandasabapathy; William Brugge; Gary W Falk; Kerry B Dunbar; Zhe Zhang; Kevin Woods; Jose Antonio Almario; Ursula Schell; John Goldblum; Anirban Maitra; Elizabeth Montgomery; Ralf Kiesslich
Journal:  Gastrointest Endosc       Date:  2013-11-09       Impact factor: 9.427

10.  The Race-Specific Incidence of Esophageal Squamous Cell Carcinoma in Individuals With Exposure to Tobacco and Alcohol.

Authors:  Anoop Prabhu; Kenneth Obi; David Lieberman; Joel H Rubenstein
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.